GB9706294D0 - Heterocyclic compound - Google Patents
Heterocyclic compoundInfo
- Publication number
- GB9706294D0 GB9706294D0 GBGB9706294.7A GB9706294A GB9706294D0 GB 9706294 D0 GB9706294 D0 GB 9706294D0 GB 9706294 A GB9706294 A GB 9706294A GB 9706294 D0 GB9706294 D0 GB 9706294D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- heterocyclic compound
- heterocyclic
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
| EP98919133A EP0971896A1 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| PCT/EP1998/001700 WO1998042673A1 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| EA199900755A EA199900755A1 (ru) | 1997-03-26 | 1998-03-24 | Производное хинолин-2-карбоновой кислоты и его применение в качестве антагониста возбуждающих аминокислот |
| YU47699A YU47699A (sh) | 1997-03-26 | 1998-03-24 | Derivat hinolin -2-karboksilne kiseline i njegova upotreba kao antagonist ekscitatornih amino kiselina |
| CA002284710A CA2284710A1 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| KR1019997008630A KR20010005567A (ko) | 1997-03-26 | 1998-03-24 | 퀴놀린-2-카르복실산 유도체 및 그의 흥분성 아미노산 길항제로서의 용도 |
| IL13191998A IL131919A0 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| AU72094/98A AU731394B2 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| BR9808424-0A BR9808424A (pt) | 1997-03-26 | 1998-03-24 | Composto, processos para a preparação do mesmo, para a preparação dos intermediários e para tratamento de um mamìfero, incluindo o ser humano, composição farmacêutica, e, uso de um composto. |
| TR1999/02315T TR199902315T2 (xx) | 1997-03-26 | 1998-03-24 | Kuinolin-2-karboksilik asit ve uyar�c� amino asit antagonisti olarak kullan�m�. |
| JP54323498A JP2001518901A (ja) | 1997-03-26 | 1998-03-24 | キノリン−２−カルボン酸誘導体およびその興奮性アミノ酸拮抗薬としての使用 |
| IDW991108A ID24306A (id) | 1997-03-26 | 1998-03-24 | Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori |
| CN98805302A CN1257482A (zh) | 1997-03-26 | 1998-03-24 | 喹啉－2－羧酸衍生物及其作为兴奋性氨基酸拮抗剂的用途 |
| HU0001661A HUP0001661A3 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| APAP/P/1999/001659A AP9901659A0 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivatives and its use as excitatory amino acids antagonist. |
| NZ337793A NZ337793A (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivatives and the use of these derivatives in the preparation of medicaments for antagonising the effect of excitatory amino acids upon the NMDA receptor complex |
| PL98335865A PL335865A1 (en) | 1997-03-26 | 1998-03-24 | Derivative of quinoline-2-carboxylic acid and application thereof as an antagonist of stimulating amino acids |
| IS5186A IS5186A (is) | 1997-03-26 | 1999-09-17 | Kínólín-2-karboxýlsýru afleiða og notkun hennar sem mótlyf fyrir örvandi amínósýrur |
| NO994679A NO994679L (no) | 1997-03-26 | 1999-09-24 | Quinolin-2-karboksylsyrederivat og anvendelse derav som eksitatorisk aminosyreantagonist |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9706294D0 true GB9706294D0 (en) | 1997-05-14 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9706294.7A Pending GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (pt) |
| JP (1) | JP2001518901A (pt) |
| KR (1) | KR20010005567A (pt) |
| CN (1) | CN1257482A (pt) |
| AP (1) | AP9901659A0 (pt) |
| AU (1) | AU731394B2 (pt) |
| BR (1) | BR9808424A (pt) |
| CA (1) | CA2284710A1 (pt) |
| EA (1) | EA199900755A1 (pt) |
| GB (1) | GB9706294D0 (pt) |
| HU (1) | HUP0001661A3 (pt) |
| ID (1) | ID24306A (pt) |
| IL (1) | IL131919A0 (pt) |
| IS (1) | IS5186A (pt) |
| NO (1) | NO994679L (pt) |
| NZ (1) | NZ337793A (pt) |
| PL (1) | PL335865A1 (pt) |
| TR (1) | TR199902315T2 (pt) |
| WO (1) | WO1998042673A1 (pt) |
| YU (1) | YU47699A (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| DE10137487A1 (de) | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| JP4360891B2 (ja) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法 |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| NZ565080A (en) | 2005-07-22 | 2011-03-31 | Mochida Pharm Co Ltd | Novel heterocyclidene acetamide derivative |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| RU2020100230A (ru) | 2017-06-12 | 2021-07-13 | Глитек Ллс. | Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0386839B1 (en) * | 1989-03-08 | 1997-01-15 | Merck Sharp & Dohme Ltd. | Tetrahydroquinoline derivatives useful for neurodegenerative disorders |
| US5977136A (en) * | 1995-09-29 | 1999-11-02 | Glaxo Wellcome Spa | Tetrahydroquinolines as NMDA antagonists |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/ko not_active Application Discontinuation
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/pt not_active IP Right Cessation
- 1998-03-24 PL PL98335865A patent/PL335865A1/xx unknown
- 1998-03-24 EA EA199900755A patent/EA199900755A1/ru unknown
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/hu unknown
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/xx unknown
- 1998-03-24 JP JP54323498A patent/JP2001518901A/ja active Pending
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
- 1998-03-24 YU YU47699A patent/YU47699A/sh unknown
- 1998-03-24 CN CN98805302A patent/CN1257482A/zh active Pending
- 1998-03-24 IL IL13191998A patent/IL131919A0/xx unknown
- 1998-03-24 ID IDW991108A patent/ID24306A/id unknown
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/is unknown
- 1999-09-24 NO NO994679A patent/NO994679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9808424A (pt) | 2000-05-23 |
| IS5186A (is) | 1999-09-17 |
| WO1998042673A1 (en) | 1998-10-01 |
| NO994679D0 (no) | 1999-09-24 |
| AP9901659A0 (en) | 1999-09-30 |
| AU731394B2 (en) | 2001-03-29 |
| EA199900755A1 (ru) | 2000-08-28 |
| TR199902315T2 (xx) | 2000-05-22 |
| JP2001518901A (ja) | 2001-10-16 |
| NO994679L (no) | 1999-11-24 |
| PL335865A1 (en) | 2000-05-22 |
| KR20010005567A (ko) | 2001-01-15 |
| EP0971896A1 (en) | 2000-01-19 |
| IL131919A0 (en) | 2001-03-19 |
| HUP0001661A2 (hu) | 2000-09-28 |
| ID24306A (id) | 2000-07-13 |
| NZ337793A (en) | 2001-02-23 |
| HUP0001661A3 (en) | 2001-12-28 |
| CA2284710A1 (en) | 1998-10-01 |
| AU7209498A (en) | 1998-10-20 |
| YU47699A (sh) | 2001-12-26 |
| CN1257482A (zh) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24041A (en) | New heterocyclic compounds | |
| IL134086A0 (en) | Novel spiroazabicyclic heterocyclic compounds | |
| GB9715892D0 (en) | Heterocyclic compounds | |
| IL132170A0 (en) | Novel heterocyclic compounds | |
| GB9800575D0 (en) | Heterocyclic compounds | |
| GB9602294D0 (en) | Heterocyclic compounds | |
| GB9617305D0 (en) | Heterocyclic compounds | |
| ZA981920B (en) | Novel heterocyclic compounds | |
| GB9706294D0 (en) | Heterocyclic compound | |
| ZA985448B (en) | Novel heterocyclic compounds | |
| PL336639A1 (en) | Novel heterocyclic compounds | |
| EP0900204A4 (en) | HETEROCYCLIC CONNECTIONS | |
| GB9706309D0 (en) | Heterocyclic compound | |
| EP0900217A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EP0900219A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EP0912183A4 (en) | HETEROCYCLIC COMPOSITIONS | |
| GB9404942D0 (en) | Heterocyclic compound | |
| ZA989421B (en) | Heterocyclic compounds | |
| GB9702945D0 (en) | Heterocyclic compounds | |
| GB9716378D0 (en) | Heterocyclic compounds | |
| GB9715734D0 (en) | Heterocyclic compounds | |
| GB9719237D0 (en) | Heterocyclic compounds | |
| GB9715735D0 (en) | Heterocyclic compounds | |
| ZA981177B (en) | Heterocyclic compounds | |
| GB9801058D0 (en) | Heterocyclic compounds |